Indeed, the specific influence of HR status on the overall prognosis of HER2-positive breast cancer remained controversial [42], and this kind of inconsistency may due to the relatively limited volume of sample size, insufficient follow-up, and the discordance in inclusion criteria. Here, ERBB2 is linked to breast carcinoma.